Chief Executive Officer
CurrentNeutargeton Therapeutics develops novel therapeutics to treat CNS disorders via targeted, non-invasive brain activation and the delivery of drugs to produce a higher on-target treatment effect.
Please complete the CAPTCHA to continue
@peartherapeutics.com
✓
1 phone found area 617
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Alex Waldron is listed as Therapeutics Business Executive at Yale Ventures, based in Greater Boston, United States, United States. AeroLeads shows a work email signal at peartherapeutics.com, phone signal with area code 617, and a matched LinkedIn profile for Alex Waldron.
Alex Waldron previously worked as Chief Executive Officer at Neutargeton Therapeutics and Entrepreneur in Residence at Yale Ventures. Alex Waldron holds Ba, International Business And Economics from Boston University.
This section adds company-level context without repeating Alex Waldron's masked contact details.
AeroLeads found 2 current-domain work email signals for Alex Waldron. Compare company email patterns before reaching out.
Executive global bio/pharmaceutical business leader with extensive experience in large pharmaceutical, fully integrated biopharmaceutical, digital healthcare, venture capital and startup organizations.
Listed skills include Cross Functional Team Leadership, Pharmaceutical Industry, Strategy, Biotechnology, and 44 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Neutargeton Therapeutics develops novel therapeutics to treat CNS disorders via targeted, non-invasive brain activation and the delivery of drugs to produce a higher on-target treatment effect.
New Haven, Connecticut, US
Wellinks, virtual-first a healthcare company on a mission to help patients with COPD live fully and breathe freely. Offering the first-ever integrated, virtual COPD management system, Wellinks supports patients through virtual pulmonary rehabilitation, health coaching, and monitoring through connected devices and an easy-to-use smartphone app.
Pear Therapeutics is a Public (NASDAQ: PEAR) digital health company focused on the development of prescription digital therapeutics and drug/software combinations to treat diseases with high unmet medical need. Pear’s patented, clinically validated approach is designed to provide enhanced outcomes for patients, actionable data for clinicians, and.
o Developed strategic insights and operational plans for bio/pharmaceutical developers, manufacturers and VC. o Asset valuation and strategic planning.
o Developed strategic insights and operational plans for bio/pharmaceutical developers, manufacturers and VC. o Asset valuation and strategic planning.
Quick answers generated from the profile data available on this page.
Alex Waldron works for Yale Ventures.
Alex Waldron is listed as Therapeutics Business Executive at Yale Ventures.
AeroLeads has found 2 work email signals at @peartherapeutics.com for Alex Waldron at Yale Ventures.
AeroLeads has found 1 phone signal(s) with area code 617 for Alex Waldron at Yale Ventures.
Alex Waldron is based in Greater Boston, United States, United States while working with Yale Ventures.
Alex Waldron has worked for Neutargeton Therapeutics, Yale Ventures, Embr Labs, Wellinks, and Pear Therapeutics.
You can use AeroLeads to view verified contact signals for Alex Waldron at Yale Ventures, including work email, phone, and LinkedIn data when available.
Alex Waldron holds Ba, International Business And Economics from Boston University.
Alex Waldron is listed with skills including Cross Functional Team Leadership, Pharmaceutical Industry, Strategy, Biotechnology, Commercialization, Global Marketing, Neurology, and Life Sciences.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts